+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Organ Transplant Immunosuppressant Drugs Market, by Drugs Class, by Therapeutic Organ Transplant Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

  • PDF Icon

    Report

  • 210 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5455985
After a successful organ transplant, you may have to take immunosuppressant drugs. These drugs help your immune system from attacking (rejecting) the new organ from which it has been transplanted. In general, they should be taken for your lifetime, or until the treatments are complete. Orally, or injected into a vein, these drugs work by stopping your body's immune cells from further attacking your transplanted organ. They also control your allergic reactions to the transplanted organ and reduce inflammation around the transplanted tissues.



Market Dynamics:


Approval and launch of new drugs is expected to propel growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, in July 2021, Kadmon Holdings, Inc. received the U.S. Food and Drug Administration approval for REZUROCK (belumosudil) for the treatment of adult and pediatric patients with chronic graft-versus-host disease.

Negative outcomes in clinical trials is expected to hinder growth of the global organ transplant immunosuppressant drugs market. For instance, in September 2021, Novartis AG announced to halt a mid-stage clinical trial of drug intended to prevent organ rejection after an early look at data in kidney transplant patients showed the experimental treatment was less effective compared to the standard of care therapy.

The market is witnessing several M&A activities. For instance, in September 2021, Sanofi announced to acquire Kadmon Holdings, a U.S.-based biopharmaceutical company.

Key features of the study:

  • This report provides in-depth analysis of the global organ transplant immunosuppressant drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market

Detailed Segmentation:


Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class:

  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • mTOR Inhibitor
  • Steroids
  • Antibodies

Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Others

Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Organ Transplant Immunosuppressant Drugs Market, By Region:

  • North America

North America Organ Transplant Immunosuppressant Drugs Market , By Country:

  • U.S.
  • Canada
  • Latin America

Latin America Organ Transplant Immunosuppressant Drugs Market , By Country:

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe

Europe Organ Transplant Immunosuppressant Drugs Market , By Drug Class:


Europe Organ Transplant Immunosuppressant Drugs Market , By Country:

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific

Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Country:

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East

Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:

  • GCC
  • Israel
  • Rest of Middle East
  • Africa

Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:

  • North Africa
  • Central Africa
  • South Africa

Company Profiles

  • Astellas Pharma*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategy
  • Genzyme Corporation
  • Accord Healthcare Ltd.
  • Watson Pharmaceuticals, Inc.
  • Novartis AG
  • Mylan Laboratories, Inc.
  • GlaxoSmithKline plc.
  • Belcher Pharmaceuticals LLC
  • Leo Pharma AS
  • Glenmark Pharmaceuticals Ltd.
  • TFF Pharmaceuticals, Inc.
  • TolerogenixX GmbH
  • Veloxis Pharmaceuticals Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Panacea Biotec Ltd.
  • Strides Pharma Global Pte Ltd.
  • F-Hoffman La Roche
Frequently Asked Questions about the Organ Transplant Immunosuppressant Drugs Market

What is the estimated value of the Organ Transplant Immunosuppressant Drugs Market?

The Organ Transplant Immunosuppressant Drugs Market was estimated to be valued at $4734.8 Million in 2021.

What is the growth rate of the Organ Transplant Immunosuppressant Drugs Market?

The growth rate of the Organ Transplant Immunosuppressant Drugs Market is 3.5%, with an estimated value of $6007.6 Million by 2028.

What is the forecasted size of the Organ Transplant Immunosuppressant Drugs Market?

The Organ Transplant Immunosuppressant Drugs Market is estimated to be worth $6007.6 Million by 2028.

Who are the key companies in the Organ Transplant Immunosuppressant Drugs Market?

Key companies in the Organ Transplant Immunosuppressant Drugs Market include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals Inc., Novartis AG, Mylan Laboratories Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC and Glenmark Pharmaceuticals Ltd..

Table of Contents

1. Research Objective and Assumption
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Transplant Type
  • Market Snippet, By Distribution Channel
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Epidemiology
  • Regulatory Scenario
  • Pipeline Analysis
  • PEST Analysis
  • Reimbursement Scenario

4. Global Organ Transplant Immunosuppressant Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
  • Covid-19 Epidemiology
  • Overall Impact On Countries
  • Key Developments

5. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Type, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Segment Trends
  • Calcineurin Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Antiproliferative Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • mTOR Inhibitor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Steroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

6. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Segment Trends
  • Kidney
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Liver
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Heart
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Lung
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Pancreas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

7. Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

8. Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape
  • Company Profiles
  • Astellas Pharma
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Genzyme Corporation
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Accord Healthcare Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Watson Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Mylan Laboratories, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • GlaxoSmithKline plc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Belcher Pharmaceuticals LLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Leo Pharma AS
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Glenmark Pharmaceuticals Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • TFF Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • TolerogenixX GmbH
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Veloxis Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Dr. Reddy’s Laboratories Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Panacea Biotec Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Strides Pharma Global Pte Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • F-Hoffman La Roche
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Astellas Pharma
  • Genzyme Corporation
  • Accord Healthcare Ltd.
  • Watson Pharmaceuticals Inc.
  • Novartis AG
  • Mylan Laboratories Inc.
  • GlaxoSmithKline plc.
  • Belcher Pharmaceuticals LLC
  • Leo Pharma AS
  • Glenmark Pharmaceuticals Ltd.
  • TFF Pharmaceuticals Inc.
  • TolerogenixX GmbH
  • Veloxis Pharmaceuticals Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Panacea Biotec Ltd.
  • Strides Pharma Global Pte Ltd.
  • F-Hoffman La Roche